• Nuclear Medicine and Molecular Imaging
• /
• 제40권2호
• /
• pp.120-126
• /
• 2006

Radionuclide therapy has been continued for treatment of incurable diseases for past decades. Relevant evaluation of absorbed dose in radionuclide therapy is important to predict treatment output and essential for making treatment planning to prevent unexpected radiation toxicity. Many scientists in the field related with nuclear medicine have made effort to evolve concept and technique for internal radiation dosimetry in this review, basic concept of internal radiation dosimetry is described and recent progress in method for dosimetry is introduced.

• BMB Reports
• /
• 제31권5호
• /
• pp.419-426
• /
• 1998

The nuclear hormone receptor superfamily currently includes approximately equal numbers of conventional receptors and orphan receptors, which do not have known ligands. Here, we review recent progress from this laboratory on three orphans, two of which are moving from orphan to conventional receptor status. Perhaps the most unusual is CAR, which is a constitutive transactivator in the absence of ligands but becomes transcriptionally inactive in the presence of its ligands, which are androgen metabolites. The response of CAR to its ligands is thus opposite to that of the conventional receptor paradigm. RIP14 (also known as FXR) is activated by both all-trans retinoic acid and a synthetic retinoid previously thought to specifically target the retinoic acid receptors (RARs), and thus appears to be a novel retinoid receptor. Finally, SHP is a novel orphan that lacks a DNA binding domain and interacts with a number of other receptor superfamily members. While it generally inhibits its targets, including CAR, the retinoid X receptor (RXR), and the estrogen receptor (ER), it stimulates transactivation by the orphan SF-1.

• 대한핵의학회지
• /
• 제34권1호
• /
• pp.1-9
• /
• 2000

The rapid progress of molecular genetic methods over the past two decades has necessitated the development of methods to detect and quantify genetic activity within living bodies. Reporter genes provide a rapid and convenient tool to monitor gene expression by yielding a readily measurable phenotype upon expression when introduced into a biological system. Conventional reporter systems, however, are limited in their usefulness for in vivo experiments or human gene therapy because of its invasive nature which requires cell damage before assays can be performed. This offers an unique opportunity for nuclear imaging techniques to develope a novel method for imaging both the location and amount of gene expression noninvasively. Current developments to achieve this goal rely on utilizing either reporter enzymes that accumulate radiolabeled substrates or reporter receptors that bind specific radioligands. This overview includes a brief introduction to the background for such research, a summary of published results, and an outlook for future directions.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권2호
• /
• pp.118-126
• /
• 2008

Statistical image reconstruction methods have played an important role in emission computed tomography (ECT) since they accurately model the statistical noise associated with gamma-ray projection data. Although the use of statistical methods in clinical practice in early days was of a difficult problem due to high per-iteration costs and large numbers of iterations, with the development of fast algorithms and dramatically improved speed of computers, it is now inevitably becoming more practical. Some statistical methods are indeed commonly available from nuclear medicine equipment suppliers. In this paper, we first describe a mathematical background for statistical reconstruction methods, which includes assumptions underlying the Poisson statistical model, maximum likelihood and maximum a posteriori approaches, and prior models in the context of a Bayesian framework. We then review a recent progress in developing fast iterative algorithms.

• Nuclear Medicine and Molecular Imaging
• /
• 제43권3호
• /
• pp.229-239
• /
• 2009

Molecular imaging strives to visualize processes in living subjects at the molecular level. Monitoring biochemical processes at this level will allow us to directly track biological processes and signaling events that lead to pathophysiological abnormalities, and help make personalized medicine a reality by allowing evaluation of therapeutic efficacies on an individual basis. Although most molecular imaging techniques emerged from the field of oncology, they have now gradually gained acceptance by the cardiovascular community. Hence, the availability of dedicated high-resolution small animal imaging systems and specific targeting imaging probes is now enhancing our understanding of cardiovascular diseases and expediting the development of newer therapies. Examples include imaging approaches to evaluate and track the progress of recent genetic and cellular therapies for treatment of myocardial ischemia. Other areas include in vivo monitoring of such key molecular processes as angiogenesis and apoptosis, Cardiovascular molecular imaging is already an important research tool in preclinical experiments. The challenge that lies ahead is to implement these techniques into the clinics so that they may help fulfill the promise of molecular therapies and personalized medicine, as well as to resolve disappointments and controversies surrounding the field.

• 대한핵의학회지
• /
• 제32권5호
• /
• pp.433-435
• /
• 1998

Recent progress of technology permits us to assess ventricular function and wall motion as well as myocardial perfusion using electrocardiographic gated myocardial perfusion single photon emission computed tomography (GM-SPECT). It is interesting that echocardiography and magnetic resonance imaging are moving in the same direction with the use of contrast medium to assess myocardial perfusion. A valid fundamental basis for a new technology is essential for a successful competition. Lee et al. report in this issue the reproducibility of serial measurement of left ventricular function including systolic wall thickening using a novel statistical method. It has important implications such as nitroglycerin or dobutamine application during GM-SPECT. The field of nuclear cardiology must continue to strive toward more sophisticated but straightforward evaluation of cardiac diseases.

• 대한핵의학회지
• /
• 제39권2호
• /
• pp.141-145
• /
• 2005

Hypoxia (decreased tissue oxygen tension) is a component of many diseases such as tumors, cerebrovascular diseases and ischemic heart diseases. Although hypoxia can be secondary to a low inspired $pO_2$ or a variety of lung disorders, the most common cause is ischemia due to an oxygen demand greater than the local oxygen supply. In the heart tissue, hypoxia is often observed in persistent low-flow states, such as hibernating myocardium. Direct "hot spot" imaging of myocardial tissue hypoxia is potentially of great clinical importance because it may provide a means of identifying dysfunctional chronically ischemic but viable hibernating myocardium. A series of radiopharmaceuticals that incorporate nitroimidazole moieties have been synthesized to detect decreased local tissue pO2. In contrast to agents that localize in proportion to perfusion, these agents concentrate in hypoxic tissue. However, the ideal agents are not developed yet and the progress is very slow. Furthermore, the research focus is on tumor hypoxia nowadays. This review introduces the myocardial hypoxia imaging with summarizing the development of radiopharmaceuticals.

• 핵의학기술
• /
• 제13권1호
• /
• pp.30-34
• /
• 2009

목적 : 현재 신속한 검사 및 환자의 대기 시간 단축에 따른 제한적인 영향을 가지고 있는 whole body bone scan의 단점을 보완하기 위한 다양한 프로그램들이 개발되어 사용되고 있다. 본 연구는 스캔속도와 알파 값에 따른 FWHM를 이용하고 영상의 육안평가를 통해서 우수한 영상의 질을 얻을 수 있는 매개변수로 임상의 유용성을 얻고자 한다. 실험재료 및 방법 : Siemens (e.cam)사의 감마카메라에서 spatial resolution phantom과 four quadrant bar phantom을 이용하였다. spatial resolution phantom을 가지고 scatter와 non scatter로 Onco Flash를 적용해서 스캔속도 15, 20, 25, 30, 35, 40 cm/min으로 FWHM을 비교하였다. 또한 Onco Flash의 알파값 (0~100%)에서 10%씩 증가하여 스캔속도 30 cm/min 기준으로 계수율과 bar phantom 영상을 얻어 육안적 평가를 하였다. 결과 : Onco Flash를 적용한 scatter에서 스캔속도에 따라 FWHM은 9.37, 9.40, 9.28, 9.30, 9.31, 9.53 mm이고, non scatter에서는 스캔속도에 따라 FWHM은 8.42, 8.32, 8.2, 8.25, 8.35, 8.52 mm이었다. 알파 값은 10%씩 증가할수록 계수율도 증가하고, 육안적 평가는 40% 이상에서 인공물이 나타나기 시작하기 때문에 알파 값은 30% 이하에서 적합하였다. 따라서 Onco Flash를 사용한 스캔속도가 25~35 cm/min에서 알파값 30% 적용 시 FWHM이 평균 9.3 mm로서 15~40 cm/min를 벗어나는 값 보다 공간분해능이 향상되었다. 결론 : Whole body bone scan의 영상을 향상시킬 수 있는 적정 매개변수를 알 수 있었으며 검사 시간을 단축하면서 영상의 질을 향상 할 수 있도록 매개변수들을 적용해 보아 임상적용에 적합한 범위를 얻어 검사자에게 유용한 지표가 될 것이라 사료된다.

• 대한핵의학회지
• /
• 제38권2호
• /
• pp.143-151
• /
• 2004

Recent progress in the development of non-invasive imaging technologies continues to strengthen the role of molecular imaging biological research. These tools have been validated recently in variety of research models, and have been shown to provide continuous quantitative monitoring of the location(s), magnitude, and time-variation of gene expression. This article reviews the principles, characteristics, categories and the use of radionuclide reporter gene imaging technologies as they have been used in imaging cell trafficking, imaging gene therapy, imaging endogenous gene expression and imaging molecular interactions. The studios published to date demonstrate that reporter gene imaging technologies will help to accelerate pre-clinical model validation as well as allow for clinical monitoring of human diseases.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권6호
• /
• pp.279-292
• /
• 2006

Recent progress in the development of non-invasive imaging technologies continues to strengthen the role of biomedical research. These tools have been validated recently in variety of research models, and have born shown to provide continuous quantitative monitoring of the location(s), magnitude, and time-variation of gene delivery and/or expression. This article reviews the use of PET technologies as they have been used in imaging biological processes for molecular imaging applications. The studies published to date demonstrate that noninvasive imaging tools will help to accelerate pre-clinical model validation as well as allow for clinical monitoring of human diseases.